1419 |
New Devices for Treatment of CLI: What Works, What Doesn\'t |
Michael R. Jaff |
May. 15. 12 |
1418 |
Angiosome Principle and Case-based Strategy for BTK Procedure |
Kazushi Urasawa |
May. 15. 12 |
1417 |
When Outcomes Matter, Design Matter |
William A. Gray |
May. 15. 12 |
1416 |
Pharmacogenomics of Clopidogrel and Its Correlation with Clinical Outcomes |
Jung-Won Suh |
May. 15. 12 |
1415 |
Polyvascular Disease & Broad Indication of Clopidogrel |
Sang Hyun Kim |
May. 15. 12 |
1414 |
Triple Antiplatelet Therapy in DES Era: Default Strategy in High Risk Population |
Seung-Whan Lee |
May. 15. 12 |
1413 |
The Limits of Platelet Oriented Treatment : Cilostazol as Multidisciplinary Approach |
Young-Hoon Jeong |
May. 15. 12 |
1412 |
PtCr EES, Beyond Promus Element: Promus Element Plus & Synergy |
Ian T. Meredith |
May. 15. 12 |
1411 |
Promus Element Clinical Program in Asan Medical Center |
Jung-Min Ahn |
May. 15. 12 |
1410 |
Latest Update of PLATINUM Trial: Promus Element Workhorse Two Year Follow-up |
Gregg W. Stone |
May. 15. 12 |